Harold Bernstein, President, R&D & CMO at Maze Therapeutics, Inc. (MAZE), sold 9,276 shares at $40.43 ($375K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Open-market sale of $375k MAZE by President, R&D & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.43 | 4,432 | $179K | 47.8% |
| 2 | $40.43 | 4,432 | $179K | 47.8% |
| 3 | $40.00 | 412 | $16K | 4.4% |
| Total | $40.41 avg | 9,276 | $375K | 100% |
| Filing → |
| MAZE | SELL | 2026-09-04 | $270K | — | Filing → |
| MAZE | SELL | 2026-09-03 | $426K | — | Filing → |
| MAZE | SELL | 2026-08-14 | $446K | — | Filing → |